Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337259
Status:
TERMINATED
Last Update Posted:
2016-02-17
First Post:
2006-06-14
Brief Title:
Gemcitabine for Marginal Zone Lymphoma
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Organization Data
Organization:
Asan Medical Center
Class:
OTHER
Study ID:
AMC 2006-60
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Asan Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Cheolwon Suh
Responsible Party Title:
ASCT team
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Asan Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |